Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2013 / Sep / A toolbox of amino acids for mAb separations (1)
Forensics

A toolbox of amino acids for mAb separations

Size exclusion chromatography (SEC) is well established for mAb aggregate analysis. As the technique has been used since the early days of monoclonal antibody (mAb) development for pharmaceutical purposes, various method improvements have evolved. For instance, the benefits of arginine on analytical SEC of mAb aggregate samples are well-known. A new application note shows how SEC of mAb aggregate samples may take advantage of other amino acid additives in the mobile phase.

09/12/2013 1 min read

Share

Recently, various approaches to improve analytical SEC have focused on reducing the analysis time. This can be achieved by staggered injection protocols or increased linear flow rates. The mobile phase composition itself leaves less room for method improvement, compared to other chromatographic modes. As soon as a certain ionic strength (inhibiting electrostatic interactions without causing hydrophobic interactions) and the pH of the mobile phase (ensuring structural integrity of proteins and the stationary phase) are set, one might think that the analysis solely depends on the particle size, packing quality and column length. However, the mobile phase composition is not at the end of its rope, in case the mentioned parameters have been set. For example, arginine and other amino acids can be added to the mobile phase to affect the aggregate recovery in SEC.

A mAb was aggregated by incubation at 75 °C for 5 min. Subsequently, the sample was analyzed via TSKgel UltraSW Aggregate 7.8 mm ID x 30 cm L with different mobile phases, all of them using virgin columns. 0.2 M lysine, arginine, proline, glutamine or sodium sulfate were added to 0.1 M sodium phosphate buffer, pH 6.7, respectively. A flow rate of 1 mL/min was applied, and 20 µl (100 µg) of the aggregated mAb samples were injected onto equilibrated columns. Figure 1 illustrates the results on aggregate recovery. Glutamine and proline show a similar behavior: the aggregates are hardly recovered for the first two injections, while the aggregate peak suddenly appears for injection #3 and #4. The rise is not as sudden for sodium sulfate, but the aggregate peak will only achieve its full size for injection #10. In opposition to these results, lysine shows an even improved aggregate recovery compared to arginine. The inter-injection variability is low, depicting the complete aggregate content for all of the injections.

Fig.1 Tosoh App Note 0813Fig. 1: Aggregate Recovery on New TSKgel UltraSW Aggregate Columns. The mobile phases contain different amino acids: lysine (yellow), arginine (red), proline (green) and glutamine (blue). Sodium sulfate was added instead of an amino acid as a reference. Lysine and arginine allow almost complete aggregate recovery starting with injection #1, while proline and glutamine led to reduced aggregate recovery compared to sodium sulfate.

Besides aggregate recovery, resolution of the different sample components, namely the monomer and the different aggregates, is crucial for accurate analysis. Clearly, there is motivation to increase resolution. Figure 2 depicts the separation profile of an aggregated mAb sample on TSKgel UltraSW Aggregate using 0.1 M sodium phosphate buffer, pH 6.7 with an addition of 0.2 M arginine. Ten injections with the arginine buffer were followed by ten injections applying sodium phosphate buffer with an addition of 0.2 M sodium sulfate, in order to compare the two buffers. Monomer aggregate resolution, as well as monomer fragment resolution is slightly improved for the amino acid buffer. 

Fig2 Tosoh App Note 0813Figure 2: Separation profile of an aggregated mAb sample on TSKgel UltraSW Aggregate. Mobile phase: 0.1 M sodium phosphate buffer containing 0.2 M arginine (red). After 10 injections, the mobile phase was switched to sodium phosphate buffer with an addition of 0.2 M sodium sulfate (grey). For both mobile phases, injection #10 is shown.

Besides arginine, both proline and glutamine provide slightly increased monomer aggregate resolution. For arginine, the fragment monomer resolution is also improved. Although these increases in resolution are not drastic, they confirm that increased resolution due to the use of an advanced mobile phase is possible and that mobile phase testing can contribute to a more reliable and robust aggregate analysis.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.